Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile
Clarify Health
MAY 19, 2020
There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.). Which physicians see these patients?
52 
Let's personalize your content